Skip to main content
. 2015 Aug 12;7(8):6739–6750. doi: 10.3390/nu7085306

Table 1.

Baseline characteristics of 192 participants by dietary phylloquinone intake.

Total Cohort
(n = 192)
Dietary Phylloquinone Intake * p-Value
<207 µg/day (n = 64) ≥207 µg/day (n = 128)
Demographical measures
 Age, years 82.8 ± 7.1 83.7 ± 5.9 82.4 ± 7.7 0.227
 Female gender, n (%) 120 (62.5) 43 (67.2) 77 (60.2) 0.343
 Social problems, n (%) 21 (10.9) 10 (15.6) 11 (8.6) 0.141
 High education level , n (%) 152 (79.2) 51 (79.7) 101 (78.9) 0.900
Clinical measures
 Body mass index, kg/m2 26.2 ± 5.4 25.8 ± 4.9 26.4 ± 5.6 0.492
 CIRS-G score, /60 8.3 ± 4.0 9.0 ± 4.4 8.0 ± 3.8 0.118
 History of stroke, n (%) 29 (15.2) 10 (15.6) 19 (15.0) 0.904
 Use of vitamin K antagonists, n (%) 31 (16.1) 11 (17.2) 20 (15.6) 0.781
 Dietary intake of phylloquinone, µg/day 319.9 ± 196.3 125.3 ± 52.1 417.1 ± 167.4 <0.001
 Low dietary intake of fatty fish and eggs , n (%) 23 (12.2) 9 (14.8) 14 (10.9) 0.453
Neuropsychiatric measures
 MMSE score, /30 21.4 ± 5.9 19.9 ± 6.2 22.0 ± 5.7 0.024
 FBRS score, /4 1.6 ± 1.2 1.9 ± 1.3 1.5 ± 1.2 0.042
Serum measures
 TSH concentration, mIU/L 1.6 ± 1.8 1.5 ± 1.2 1.7 ± 2.0 0.440
 Vitamin B12 concentration, ng/L 444.3 ± 266.2 478.5 ± 375.8 427.4 ± 190.6 0.228
 Albumin concentration, g/L 34.9 ± 5.5 33.0 ± 5.7 35.9 ± 5.2 0.001
 Estimated glomerular filtration rate, mL/min 53.7 ± 21.9 50.8 ± 18.2 55.1 ± 23.5 0.217

Data presented as mean ± standard deviation when applicable. CIRS-G: Cumulative Illness Rating Scale for Geriatrics; FBRS: Frontotemporal Behavioral Rating Scale; MMSE: Mini-Mental State Examination; TSH: thyroid stimulating hormone; *: lower dietary phylloquinone intake defined as the lowest third (i.e., below 206.97 µg/day); higher dietary phylloquinone intake defined as the other two thirds combined (i.e., above 206.97 µg/day); : Elementary School Recognition Certificate passed; : Answer “No” to the question “Do you eat fatty fish at least once a week and/or eggs several times per week?”; p-values < 0.05 indicated in bold.

HHS Vulnerability Disclosure